WHEN CUSTOMIZING, INCLUDE ONLY LABS, DRUGS, & PROCEDURES PROVIDED ONSITE FAMILY PLANNING SERVICES



Similar documents
Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes

Medicaid Family Planning Waiver Services CPT Codes and ICD-9 Diagnosis Codes

Clinical Scenarios CODING AND BILLING 101. Daryn Eikner, Family Planning Council Ann Finn, Ann Finn Consulting

Michael Policar, MD, MPH, Presenter. Fundamentals of Family Planning Coding: Family Planning, Access, Care, and Treatment (Family PACT) and Medi Cal

Best Practices in Reproductive Health: CPT and ICD-9 Coding

Chapter 101 MAINECARE BENEFITS MANUAL CHAPTER III

Plan First! Rev: 06/25/2015 Family Planning Waiver Program Covered Services January 2015

Treatment of sexually transmitted and other genital infections

Sexually Transmitted Infections (STI) One Day Update

CODING GUIDELINES FOR CONTRACEPTIVES. Updated for ICD-10 CM (post October 1, 2015)

Advanced Coding Case Studies Reproductive Health Care

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.

Advanced Coding Case Studies Reproductive Health Care

2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential. STD Treatment Guidelines. How are the guidelines prepared?

Birth Control Options

INTRODUCTION: CPT CODES & ICD-9 CODES

ICD-10 Are You Ready?

Diseases that can be spread during sex

THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE

STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)

Management of Abnormal PAP Smears. K Chacko, MD, FACP 2010 GIM Conference

Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011

Fee Schedule Instructions

SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization

CONTRACEPTION TYPES CONTRACEPTION LARA SANDERS, RN CHAPTER 7 PAGES

Leader's Resource. Note: Both men and women can have an STD without physical symptoms.

Effective Coding Practices in Reproductive Health Care

Fundamentals of Coding and Billing for STI Clinical Services in Local Health Departments

Texas Billing and Coding Guide. A Resource for Providers of HIV, STD and Related Services

9/28/2015. Sexually Transmitted Infections. STDs in Minnesota: Number of Cases Reported in 2013*

TREATMENT OF STI CONTACTS

Tracy Irwin, MD, MPH Assistant Professor University of Illinois at Chicago. Men, Women, Both # in what period of time (i.e.

SECTION 1.1 PERSONNEL

WOOD COUNTY SCHOOL OF PRACTICAL NURSING. Medical/Surgical Nursing: Reproductive

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

Coding for the Contraceptive Implant and IUDs

101 CMR: EXECUTIVE OFFICE OF HEALTH AND HUMAN SERVICES 101 CMR : FAMILY PLANNING SERVICES

California Guidelines for STD Screening and Treatment in Pregnancy

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

Slide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know. Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know.

NEW YORK STATE Department of Health

Provider Handbooks. Gynecological and Reproductive Health and Family Planning Services Handbook

Frequently Asked Questions

Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon

Urinary Tract Infections

Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012

SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS

STI case management. Francis Ndowa - GFMER Theodora Wi - WHO

Guidelines for Preventative Health Care in LGBT Populations

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

Abigail R. Proffer, M.D. October 4, 2013

WELCOME TO COLLEGE HEIGHTS OBGYN ASSOCIATES

Stay Healthy at Any Age!

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS

Birth Control Methods

All methods of birth control are MUCH SAFER than being pregnant! If 100 women use each method for a year, how many of them get pregnant?

STD Treatment Guidelines

PRENATAL/WOMEN S HEALTH ROTATION

Cancer of the Cervix

Glossary. amenorrhea, primary - from the beginning and lifelong; menstruation never begins at puberty.

Rhode Island Department of Health Division of Infectious Diseases and Epidemiology

California Gonorrhea Treatment Guidelines

2010 STD Treatment Guidelines: Update for Primary Care Providers

Family Planning Services Clinical Coverage Policy No: 1E-7 Amended Date: October 1, Table of Contents

Appropriate Treatment for Children with Upper Respiratory Infection

Something for Everyone!

Cervical Cancer Screening and Management Guidelines: Changing Again, Huh?

WA Endemic Regions STI/HIV Control Supplement

Measure Name: URI Treatment without Antibiotics for Children Measure Code: URI Lab Data: N

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL ABNORMAL PAP SMEAR (ABNORMAL CERVICAL CYTOLOGIC FINDINGS) Kathleen Dor

American Academy of Family Physicians

Illinois Insurance Facts Illinois Department of Insurance

F REQUENTLY A SKED Q UESTIONS. Birth Control. A: There are many methods of birth con- ents. Making decisions about birth

Pap smears, cytology and CCHC lab work and follow up

signs suggesting chlamydia:

Cervical Cancer Prevention and Early Detection What is cervical cancer?

Cervical Screening and HPV Vaccine Guidelines In Saudi Arabia. Prof. Mohammed Addar Chairmen Gyneoncology section KKUH, King Saud University

GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS

Examples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.

Copper-Bearing Intrauterine Device

Balanitis (change on the helmet of the penis) This is a change in the skin on the glans (helmet) of the penis. It is often caused by either:-

A PRINTED copy of this guideline may not be the most recent version. The OFFICIAL version is located on IHNET at the Policies & Procedures Home Page

Sage Screening Program. Provider Manual

Effective long-lasting strategy to prevent unintended pregnancy. The intrauterine system for contraception after abortion.

Cervical Cancer The Importance of Cervical Screening and Vaccination

Have a shower, rather than a bath to avoid exposing your genitals to the chemicals in your cleaning products for too long. Always empty your bladder

Billing and Coding Manual for Title X Family Planning Clinics

Aetna Life Insurance Company

12/3/2015. M genitalium and urethritis and cervicitis. Consider M gent Rx in persistent /recurrent urethritis and in persistent cervicitis and PID

Women s Health Issues

WASHINGTON STATE DEPARTMENT OF HEALTH FAMILY PLANNING AND REPRODUCTIVE HEALTH ON-SITE MONITOR TOOL FOR TITLE X AGENCIES

Emergency Contraceptive Pills

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Sterilisation for women and men: what you need to know

Accent on Health Obgyn, PC HPV Frequently Asked Questions

CERVICAL CANCER What every woman should know What is a cervix?

SECTION 1.11 RISK MANAGEMENT / QUALITY ASSURANCE POLICY

Transcription:

Family PACT Sample WHEN CUSTOMIZING, INCLUDE ONLY LABS, DRUGS, & PROCEDURES PROVIDED ONSITE Client Name: DOB: Service Date: Telephone: Alt. Contact: M.R. # HAP #: Exp. Date: Return: FAMILY PLANNING SERVICES Family Planning Diagnosis Codes ICD-10-CM Codes Contraceptive-related Laboratory Tests Z30.012 EC counseling and prescription See PPBI ben fam and lab for covered tests Z30.09 Contraceptive counseling & advice and restricitions. (without initiating method) Z30.011 OC initial prescription STI Risk Factor ICD-10-CM Codes: Z30.41 OC surveillance GC/CT Screening Z30.018 Initial prescription (patch, ring) Codes are required by Laboratory Z30.49 Surveillance (patch, ring) Providers Z30.013 Injectable contraceptive initiation Z20.2 Contact with/exposure to STI(s) Z30.42 Injectable contraceptive surveillance Z22.4 Carrier of STI (s) Z30.018 Subdermal implant insertion Z72.51 High risk heterosexual behavior Z30.8 Subdermal implant surveillance Z72.52 High risk homosexual behavior Z30.430 IUC insertion Z72.53 High risk bisexual behavior Z30.431 IUC surveillance Z86.19 Retest 3 month post treatment Z30.432 IUC removal GC/CT Z30.433 IUC removal and reinsertion Z11.3 High prevalence locality Z30.019 Female barrier/spermicide initiate (F) (GC >1%) Z30.9 Male condoms/spermicide initiate (M/F) Z11.8 High prevalance locality Z30.40 Barrier/spermicide surveillance (M/F) (CT >3%) Z30.02 Counsel NFP to avoid pregnancy Z31.61 Procreative counseling, NFP Diagnostic STI Services Z30.09 Counseling on sterilization (M/F) See PPBI ben fam rel for covered lab tests, Z30.2 Sterilization surgery (M/F) services and restrictions. Z01.812 Preprocedure labs (M/F) Use back of Superbill. (bill with Z30.09) Z01.818 Preprocedure exam (F) (bill with Z30.09) Z98.51 Tubal ligation status Z98.52 Vasectomy status

FAMILY PLANNING SERVICES Office Visit Office Procedures New Client Education & Management See Medi-Cal Part 2 for surgical & supplies 99201 Problem Focused or 10 mins (M/F) modifiers 99202 Expanded Problem Focused or 11981 Implant insertion 20 mins (M/F) 11976 Implant removal 99203 Detailed or 30 mins (M/F) 58300 Insert IUC 99204 Comprehensive or 45 mins (F) 58301 Remove IUC Complications Only (M) 55250 Vasectomy 57170 Diaphragm fitting Established Client Education & Management 58565 Hysteroscopic sterilization 99211 Minimal or 5 mins (M/F) (Essure) 99212 Problem Focused or 10 mins (M/F) 99213 Expanded Problem Focused or Additional Procedures (no TAR required) 15 mins (M/F) Z30.431IUC surveillance 99214 Comprehensive or 25 mins (F) Indication: missing IUC Complications Only (M) strings/malpositioned IUC 74000 X-ray exam abdomen; single AP Education & Counseling 76830 Ultrasound, transvaginal S9446 Group (M/F) or 76857 Ultrasound, pelvic (non-ob); S9445 Individual 10 mins (M/F) limited strings/malpositioned IUC 99401 U6 15 mins counseling time (M/F) Z30.8 Subdermal implant surveillance 99402 U6 30 mins counseling time (M/F) Indication: Impalpable subdermal implant 99403 U6 45 mins counseling time (M/F) 73060 X-ray exam, humerus, two views One time only codes. See PPBI office. 76882 Ultrasound, extremity; limited Time interval if more than 50% was spent on counseling. See PPBI office. No more than one per day and two visits, in any combination, in rolling 30 days. See PPBI office. Page 2 of 7 Rev. 10/01/15

FAMILY PLANNING SERVICES Drugs/Contraceptive Supplies/Devices Labs Provider Performed Provider administered drugs & onsite dispensing (with CLIA Certification) must include NDC. 81025 Urine pregnancy test A4264 Intratubal microinsert (Essure) 85013 HCT, spun (modifier -50 or -52) (see PPBI for restrictions) A4267 Male condoms 85014 Hematocrit A4268 Female condoms (see PPBI for restrictions) A4269 U1 Spermicide gel/jelly/foam/cream 85018 Hemoglobin A4269 U2 Spermicidal suppository (see PPBI for restrictions) A4269 U3 Spermicidal vaginal film 86701 HIV-1 A4269 U4 Spermicidal sponge 86703 HIV-1 & HIV-2 single result S5199 Lubricant See back for additional provider performed S4993 OCs lab tests. J3490 U8 DMPA injection J7303 Ring Blood Draw & Handling J7304 Patch 99000 Blood specimen handling and/or J3490 U5 EC - ulipristal acetate* conveyance to unaffiliated lab J3490 U6 EC - levonorgestrel* J7307 Etonogestrel Implant J7300 Copper IUD J7301 Levonorgestrel IUD 13.5 mg J7302 Levonorgestrel IUD 52mg S5000** or Estradiol (with code N92.1) S5001** * One (1) pack per dispensing, with a combined (ulipristal acetate and levonorgestrel) maximum of six (6) packs in any 12-month period. ** See reverse for additional use of S5000/S5001. See PPBI ben grid and drug for contraceptive maximum quantity and earliest refill. Complication Management (TAR Required) See PPBI ben fam and ben fam rel for codes and services for management of complications. Complication ICD-10-CM Code Additional ICD-10-CM Code Procedure/Code(s): Supplies/Code(s): Other Services/Code(s): Page 3 of 7 Rev. 10/01/15

Acknowledgement By signing below, I acknowledge that I have received the services noted on this form including products/presecriptions, drugs/devices given onsite or by written order, and/or that I have given a specimen for the performance of a laboratory test or examination. Print Name: Signature: Print Clinician Name: Date: Clinician Signature: Date: Itemize dose, quantity, cost, and dispensing fee of Drugs/Supplies in ADDITIONAL CLAIM INFORMATION or REMARKS field on claim. Page 4 of 7 Rev. 10/01/15

Family PACT Sample WHEN CUSTOMIZING, INCLUDE ONLY LABS, DRUGS, & PROCEDURES PROVIDED ONSITE FAMILY PLANNING - RELATED SERVICES Chlamydia Herpes, Genital A56.01 Ct, cystitis/urethritis (M/F) A60.01 Herpesviral infection of penis A56.09 Ct, lower GU, cervix (F) A60.04 Herpesviral vulvovaginitis A56.3 Ct, anus and rectum (M/F) N48.5 Ulcer of penis N34.2 Other urethritis (M) N76.6 Ulceration of vulva N45.3 Epididymo-orchitis (M) Drugs Quantity/NDC: N72 Cervicitis (F) Acyclovir 200/400/800 mg** N89.8 Indication: Leukorrhea NOS (F) N94.1 Dyspareunia (F) Warts, Genital Only R10.2 Pelvic and perineal pain (F) A63.0 Anogenital warts (M/F) R30.0 Dysuria (M/F) B07.9 Viral warts, unspec (M/F) R30.9 Painful micturition, unspec (M/F) B08.1 Molluscum contagiosum (M/F) Z20.2 Ct exposed partner (M/F) Procedures Labs See Medi-Cal Part 2 for surgical and supplies 87205 Gram stain (symptomatic males only) modifiers. Drugs Quantity/NDC: 54050 Chem destr, penile lesion Q0144 Azithromycin 500 mg tabs/1gm pkt 54056 Cryo destr, penile lesion Doxycycline 100 mg tabs** 54100 Biopsy, penis 56501 Destruction vulvar lesion 57061 Destruction vaginal lesion Gonorrhea 56605 Biopsy, vulva A54.01 GC cystitis/urethritis, unspec (M/F) Drugs Quantity/NDC: A54.03 GC cervicitis, unspec (F) Imiquimod 5% cream** A54.22 GC prostatitis (M) Podofilox 0.5% solution/gel** A54.5 GC pharyngitis (M/F) A54.6 GC infection anus/rectum (M/F) Syphilis N34.2 Other urethritis (M) A51.0 Primary (M/F) N45.3 Epididymo-orchitis (M) A51.31 Condyloma latum (M/F) N72 Cervicitis (F) A51.39 Other secondary syphilis of skin N89.8 Indication: Leukorrhea NOS (F) (M/F) N94.1 Dyspareunia (F) A51.5 Early syphilis, latent (M/F) R10.2 Pelvic & perineal pain (F) A52.8 Late syphilis, latent (M/F) R30.0 Dysuria (M/F) A53.0 Latent syphilis, unspec (M/F) R30.9 Painful micturition, unspec (M/F) N48.5 Ulcer of penis (M) Z20.2 GC exposed partner (M/F) N76.6 Ulceration of vulva, unspec (F) Labs Z20.2 Syphilis exposed partner (M/F) 87205 Gram stain (symptomatic males only) Drugs Quantity/NDC: Drugs Quantity/NDC: J0561 Benzathine PCN 100,000 units/cc Cefixime 400 mg tab** J0696 Ceftriaxone 250 mg IM Q0144 Azithromycin 500 mg tabs/1 gm pkt Doxycyline 100 mg tabs** Page 5 of 7

Trichomoniasis Urinary Tract Infections (Females Only) A59.01 Trichomonal vulvovaginitis (F) N30.00 Acute cystitis without hematuria A59.03 Trichomonal cystitis & urethritis N30.01 Acute cystitis with hematuria (M/F) R10.30 Lower abdominal pain, unspec N34.2 Other urethritis (M) R30.0 Dysuria Z20.2 Trichomoniasis exposed partner R30.9 Painful micturition, unspec (M/F) R31.0 Gross hematuria Labs R35.0 Frequency of micturition 83986 ph (Females only) Labs (symptomatic females only) Q0111 Wet mount (provider performed) 81000 Urinalysis, dipstick with micro Drugs Quantity/NDC: 81002 Urinalysis dipstick without micro Metronidazole 500 mg tabs** 81015 Urine microscopy Drugs Quantity/NDC: Cephalexin 250/500 mg tabs** Vulvovaginitis Ciprofloxacin 250 mg tabs** B37.3 Candidiasis vulva/vagina TMP/SMX 80/400 mg tabs** N76.0 Acute vaginitis TMP/SMX DS 160/800 mg tabs** Labs 83986 ph (females only) Cervical Abnormalities Q0111 Wet mount (provider performed) N88.0 Leukoplakia, cervix Drugs Quantity/NDC: R87.610 ASC-US cervical smear R87.611 ASC-H cervical smear Vaginal candidiasis: R87.612 LGSIL cervical smear Clotrimazole 1%/2% cream** R87.613 HGSIL cervical smear Fluconazole 150 mg tab** R87.810 Cervical high risk HPV DNA Miconazole 2%/4% cream; positive 100/200mg vaginal suppository** Z87.410 Personal history of cervical Drugs Quantity/NDC: dysplasia Procedures Bacterial vaginosis: See Medi-Cal Part 2 for surgical and supplies Metronidazole 250/500 mg tabs; modifiers. 0.75% vaginal gel** 57452 Colposcopy Clindamycin 2% cream** 57454 Colpo with biopsy & ECC For alternative regimens, see PBI ben grid. 57455 Colpo with biopsy 57456 Colpo with ECC PID (Females) 58110 Endometrial biopsy + Colpo N70.03 Acute salpingitis & oophoritis N70.93 Salpingitis & oophoritis, unspec N94.1 Dyspareunia R10.2 Pelvic & perineal pain Drugs Quantity/NDC: J0694 Cefoxitin 1 gm IM J0696 Ceftriaxone 250 mg IM Doxycycline 100 mg tabs** Probenecid 500 mg tabs** Metronidazole 250/500 mg tabs** Page 6 of 7

Cervical Abnormalities (con't) N87.0 Mild cervical dysplasia CIN 1 N87.1 Moderate cervical dysplasia CIN 2 D06.9 Carcinoma in situ of cervix CIN 3 Procedures See Medi-Cal Part 2 for surgical and supplies modifiers. 57452 Colposcopy 57454 Colpo with biopsy & ECC 57455 Colpo with biopsy 57456 Colpo with ECC 57460 LEEP 57511 Cryocautery of cervix R87.618 Other abn findings of cervical smear Procedures See Medi-Cal Part 2 for surgical and supplies modifiers. 58100 Endometrial biopsy (ages 40) ** Use S5000 for generic drugs. Use S5001 for brand name drugs. NDC required for physician administered drugs and onsite dispensing. Onsite dispensing of Miscellaneous Drugs (S5000/S5001) is restricted to hospital outpatient departments, emergency rooms, surgical clinics, and community clinics. Itemize dose, quantity, cost, and dispensing fee of Drugs/Supplies in ADDITIONAL CLAIM INFORMATION or REMARKS on claim. Page 7 of 7